PD-L1 antibody

PD-L1-mediated immune evasion in triple-negative breast cancer is linked to the loss of ZNF652.

WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression. Wu M et al., 2021 Jun 9, Nat Commun

Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia. Liu BL et al., 2020 Oct 15, JCI Insight

The extracts of Astragalus membranaceus overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression. Chang HL et al., 2020, Int J Med Sci

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer. Qin G et al., 2020 Apr 3, Nat Commun

The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography. Wang LA et al., 2016 Jun, Tumour Biol